CRIS Current Research Information System

FESTI, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.009
AS - Asia 12.330
EU - Europa 8.942
AF - Africa 806
SA - Sud America 660
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 3
Totale 37.771
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.826
SG - Singapore 3.403
VN - Vietnam 3.368
CN - Cina 2.952
GB - Regno Unito 2.202
IT - Italia 1.598
DE - Germania 1.172
SE - Svezia 1.031
HK - Hong Kong 710
IN - India 637
FR - Francia 592
RU - Federazione Russa 475
BR - Brasile 451
UA - Ucraina 401
IE - Irlanda 376
BD - Bangladesh 247
NL - Olanda 242
ZA - Sudafrica 240
JP - Giappone 221
CI - Costa d'Avorio 187
KR - Corea 180
EE - Estonia 164
CH - Svizzera 141
FI - Finlandia 141
SC - Seychelles 119
TG - Togo 112
CA - Canada 108
BG - Bulgaria 93
JO - Giordania 86
PH - Filippine 86
AR - Argentina 76
NG - Nigeria 71
TH - Thailandia 71
PL - Polonia 57
TR - Turchia 55
ID - Indonesia 54
PK - Pakistan 51
ES - Italia 44
MX - Messico 44
EC - Ecuador 42
BE - Belgio 39
TW - Taiwan 39
GR - Grecia 37
IQ - Iraq 37
AT - Austria 36
IR - Iran 24
LT - Lituania 23
CL - Cile 21
EG - Egitto 21
SA - Arabia Saudita 20
AU - Australia 19
VE - Venezuela 17
LB - Libano 15
CO - Colombia 14
PY - Paraguay 14
CZ - Repubblica Ceca 12
ET - Etiopia 12
HR - Croazia 12
MY - Malesia 12
PE - Perù 12
PT - Portogallo 12
UZ - Uzbekistan 12
KE - Kenya 10
AL - Albania 9
BO - Bolivia 9
TN - Tunisia 9
RO - Romania 7
AZ - Azerbaigian 6
BA - Bosnia-Erzegovina 5
CR - Costa Rica 5
HN - Honduras 5
IL - Israele 5
KZ - Kazakistan 5
MA - Marocco 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
AO - Angola 4
DZ - Algeria 4
RS - Serbia 4
SI - Slovenia 4
UY - Uruguay 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
JM - Giamaica 3
KG - Kirghizistan 3
NI - Nicaragua 3
OM - Oman 3
SN - Senegal 3
SY - Repubblica araba siriana 3
BB - Barbados 2
BS - Bahamas 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
TL - Timor Orientale 2
TT - Trinidad e Tobago 2
Totale 37.742
Salva come PNG Salva come JPEG
Città #
Singapore 2.337
Southend 1.966
Fairfield 1.763
Ashburn 1.492
Chandler 1.064
San Jose 705
Ho Chi Minh City 691
Hong Kong 659
Hanoi 638
Santa Clara 635
Woodbridge 604
Seattle 595
Houston 564
Wilmington 540
Princeton 474
Cambridge 453
Dong Ket 398
Beijing 397
Dublin 375
Ann Arbor 366
Boardman 343
Hefei 340
Bologna 293
New York 255
Jacksonville 233
Lauterbourg 231
Los Angeles 218
Nanjing 207
Council Bluffs 199
Westminster 192
Abidjan 187
Tokyo 187
Padova 156
Dallas 153
Seoul 134
Berlin 128
Milan 128
Buffalo 121
Da Nang 120
Haiphong 114
Lomé 112
Bern 110
Frankfurt am Main 107
Medford 103
Saint Petersburg 102
San Diego 99
Helsinki 95
São Paulo 91
Sofia 89
Amman 86
Jinan 86
Shenyang 78
Redondo Beach 75
Turin 75
Changsha 74
Munich 73
Rome 70
Abeokuta 69
Dearborn 68
Bremen 65
Guangzhou 63
Shanghai 63
Las Vegas 62
Tianjin 58
Des Moines 57
Hebei 57
Florence 56
Nanchang 56
Johannesburg 51
Redwood City 46
Orem 45
Jiaxing 44
Mahé 41
Phoenix 41
Biên Hòa 40
The Dalles 39
Yubileyny 38
Bangkok 36
Bengaluru 36
Chicago 36
Mülheim 36
North Charleston 36
Turku 36
Brussels 35
Zhengzhou 35
Toronto 34
Hangzhou 33
London 33
Hải Dương 32
San Francisco 32
Falkenstein 31
Pune 31
Redmond 31
Washington 31
Norwalk 29
Xi'an 29
Can Tho 28
Hyderabad 28
Wuhan 28
Atlanta 27
Totale 23.982
Salva come PNG Salva come JPEG
Nome #
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 332
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 302
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 287
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 287
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 278
Ablation for hepatocellular carcinoma: beyond the standard indications 269
A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease 260
How to clarify the Baveno VI criteria for ruling out varices needing treatment by noninvasive tests 259
The importance of HCV on the burden of chronic liver disease in Italy: A multicenter prevalence study of 9,997 cases 258
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 256
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 255
Clinical application of faecal calprotectin in ulcerative colitis patients 249
G-CSF administration is not related to Peg-IFN alfa-2b treatment duration nor response in liver transplanted patients with HCV recurrence. 245
Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis 245
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 241
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 237
Sarcopenia predicts ascitic decompensation and mortality independently of portal hypertension status in patients with advanced chronic liver disease outside the liver transplantation setting 233
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 232
The aetiology of chronic hepatitis in Italy: Results from a multicentre national study 228
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 226
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 221
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 221
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 221
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 217
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 216
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 213
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 212
Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach 211
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 211
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 208
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 204
Chronic hepatitis B in Italy: New features of an old disease - Approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection 203
Benign hepatic nodular lesions after treatment for childhood cancer 202
Interleukin 28 polymorphisms and hepatocellular carcinoma development after direct acting antiviral therapy for chronihepatitis c 202
Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch–Anal Anastomosis for Ulcerative Colitis 200
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 200
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 199
H 2breath testing for other gas-related syndromes 196
Gut Microbiota and Celiac Disease 194
Corrigendum to “Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study” [Dig. Liver Dis. 49 (2017) 802–808](S1590865817302463)(10.1016/j.dld.2017.03.001) 194
Body weight,lifestyle,dietary habits and gastroesophageal reflux disease 192
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 191
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 189
“Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?” 188
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant: Results of an open, uncontrolled multicenter study 188
HCV infection is a risk factor for gallstone disease in liver cirrhosis: An Italian epidemiological survey 186
The non‐invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study 185
Silybin and the liver: from basic research to clinical practice 184
DIAGNOSTIC ACCURACY OF LIVER AND SPLEEN STIFFNESS MEASUREMENT FOR PORTAL HYPERTENSION USING BIDIMENSIONAL SHEAR WEAVE ELASTOGRAPHY 184
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 184
Probiotics, Prebiotics and Other Dietary Supplements for Gut Microbiota Modulation in Celiac Disease Patients 184
Plasma antioxidant enzymes and clastogenic factors as possible biomarkers of colorectal cancer risk 183
Dieta e microbiota intestinale: Due facce di una stessa medaglia? 182
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 182
Are noninvasive methods clinically useful in advanced, decompensated liver cirrhosis when "les Jeux Sont Faits"? 181
"Alimentazione e salute: Strategie nutrizionali per la prevenzione delle malattie”. 19 gennaio 2006 - Oratorio San Filippo Neri – Via Manzoni, 5 - Bologna. 180
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 179
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 179
null 179
Sleisenger e Fordtran. Malattie gastrointestinali ed epatiche. Fisiopatologia, diagnosi e trattamento 178
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 176
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 175
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 175
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 174
Pharmacological modulation of MRP2 in primary biliary cirrhosis 173
Ductal stones recurrence after extracorporeal shock wave lithotripsy for difficult common bile duct stones: Predictive factors 173
Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker 173
Alimentazione e salute: Linee guida per il Consumatore Bolognese, 29 aprile 2004. Oratorio S.Filippo Neri, Via Manzoni, 5 - Bologna 172
Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT 172
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. 171
Efficacy of ursodeoxycholic acid administration on clinical manifestations of gallstones and gastrointestinal motility 170
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 170
Nerve fiber overgrowth in patients with symptomatic diverticular disease 169
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 168
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 168
Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review 167
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon 166
Focal nodular hyperplasia of the liver in children after hematopoietic stem cell transplantation. 165
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study 165
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices 165
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 164
Proton pump inhibitors in cirrhosis: tradition or evidence based practice? 164
Comparison of prognostic models in predicting survival of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: a multicenter cohort study 164
Porto-sinusoidal vascular disorder in surgical candidates for liver metastases: prevalence, non-invasive diagnosis, and burden on surgical outcomes 164
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 163
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project). 163
Indocyanine Green 15-min Retention test (ICG-r15) as a predictor of clinical decompensation in patients with compensated liver cirrhosis. 163
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 163
Treatment of nonalcoholic fatty liver with focus on emerging drugs 162
Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor? 162
A new point-of-care portable immunosensor for non-invasive assessment of oro-ileal transit time by oral fluid tauroursodeoxycholate measurement after its oral load. 161
Dietary Management in IBS Patients 161
Curcumin and fennel essential oil improve symptoms and quality of life in patients with irritable bowel syndrome 161
Biliary symptoms, gallbladder motility, and cholecystectomy 160
Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma. 160
Non-invasive diagnostic approach to non-alcoholic fatty liver disease: Current evidence and future perspectives 160
Indocyanine green clearance (ICG) as a predictor of 2-years clinical decompensation and mortality in patients with compensated liver cirrhosis 160
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 159
Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update 159
Indocyanine Green Clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis 159
Totale 19.641
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.617
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.617
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021916 0 0 0 0 0 0 0 0 0 0 0 916
2021/20224.816 343 172 246 271 402 218 113 251 170 247 1.674 709
2022/20234.485 484 603 254 568 314 358 124 234 830 104 349 263
2023/20241.445 70 231 109 151 109 391 71 71 70 76 49 47
2024/20255.127 206 864 503 330 913 246 381 136 63 380 218 887
2025/202612.507 988 1.084 1.156 788 1.277 703 1.488 373 2.666 967 553 464
Totale 38.439